Trulieve Cannabis Corp. (TSE:TRU – Free Report) – Equities research analysts at Seaport Res Ptn issued their Q1 2025 earnings per share (EPS) estimates for shares of Trulieve Cannabis in a report released on Wednesday, March 5th. Seaport Res Ptn analyst S. Randhawa expects that the company will post earnings of ($0.07) per share for the quarter. Seaport Res Ptn also issued estimates for Trulieve Cannabis’ Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.03) EPS, Q4 2025 earnings at $0.03 EPS, FY2025 earnings at ($0.13) EPS, Q1 2026 earnings at ($0.03) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at $0.01 EPS and FY2026 earnings at ($0.04) EPS.
TRU has been the topic of a number of other reports. Roth Capital upgraded Trulieve Cannabis to a “strong-buy” rating in a research note on Monday, March 3rd. Craig Hallum upgraded Trulieve Cannabis to a “strong-buy” rating in a research note on Wednesday, February 26th. Cormark upgraded Trulieve Cannabis from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 3rd. Finally, Atb Cap Markets upgraded Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th.
Trulieve Cannabis Price Performance
Insider Buying and Selling at Trulieve Cannabis
In other Trulieve Cannabis news, Senior Officer Wes Getman acquired 9,500 shares of the company’s stock in a transaction on Friday, December 13th. The shares were acquired at an average cost of C$7.02 per share, with a total value of C$66,702.35.
About Trulieve Cannabis
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Featured Articles
- Five stocks we like better than Trulieve Cannabis
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Insider Buying Explained: What Investors Need to Know
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
